Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

CAR-T and Other Cellular Therapies in CLL: The Present and Future

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

Recorded August 2, 2022

Cellular therapies are a special type of immunotherapy that use cells, a “living drug”, to treat CLL / SLL. CAR-T is a revolutionary therapy in CLL and other blood cancers, which is currently available through clinical trials. Learn more about this “living drug” and other cellular therapy options for CLL patients with Dr. Mazyar Shadman.


Robyn Brumble
Director of Scientific Affairs
CLL Society



Brian Koffman, MDCM (retired), MS Ed
Co-Founder, Executive Vice President, and Chief Medical Officer
CLL Society 


Mazyar Shadman - CLL Society

Mazyar Shadman, MD, MPH
Associate Professor, Division of Medical Oncology
University of Washington School of Medical Oncology
Associate Professor, Clinical Research Division
Fred Hutchinson Cancer Research Center

This program is made possible by grant support from AstraZeneca, BeiGene, Bristol Myers Squibb, Janssen, and Pharmacyclics.